Skip to main content
U.S. flag

An official website of the United States government

Published Date: 

Mechanisms Underlying Hazardous Alcohol Use After Mild Traumatic Brain Injury

Makenzie Patarino,1,2,3,4 ORCID logo Jenna Sanders,1,3 ORCID logoand Abigail G. Schindler1,2,3,4,5,6 ORCID logo

1Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington

2Graduate Program in Neuroscience, University of Washington, Seattle, Washington

3Center for Neurobiology of Addiction, Pain & Emotion, University of Washington, Seattle, Washington

4VA Northwest Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington

5VA Northwest Mental Illness Research, Education and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington

6Department of Medicine, University of Washington, Seattle, Washington

    Abstract

    PURPOSE: Alcohol use disorder (AUD) and mild traumatic brain injury (mTBI) have a bidirectional, synergistic, and complicated relationship. Although it is difficult to definitively say that mTBI causes AUD, certain biological mechanisms that occur after trauma are also associated with hazardous alcohol use. Hazardous drinking is defined as any quantity or pattern of alcohol consumption that places people at risk for physical and/or psychological harm. This review explores how the physiological, emotional, and behavioral consequences of mTBI may lead to worse outcomes after hazardous alcohol use and increase the risk for AUD. AUD is one of the most common comorbid conditions that occurs after mTBI, and thus a clear understanding of the mechanistic changes that influence its onset may help to identify preventative and therapeutic measures for individuals who are at risk. This review provides an overview of recently published studies (from 2021 to 2024) and how these new findings fit into the existing literature.

    SEARCH METHODS: This review was conducted by searching “alcohol, traumatic brain injury, TBI” in PubMed, Google Scholar, and Medline databases in October and December 2024. Only articles in English were reviewed. Titles, abstracts, and methods of all articles were read to determine relevance, then the full texts of articles that met inclusion criteria were obtained. The search included articles published after March 2021; relevant papers published before 2021 were identified by consulting previously published reviews on this topic. Articles were excluded if they only discussed (1) moderate/severe TBI, (2) adolescent populations or TBI during adolescence, (3) populations with a history of AUD before TBI, (4) acute outcomes after TBI (less than 2 weeks), or (5) prevalence or effects of TBI while intoxicated. Also excluded were papers that did not specify if TBI preceded or followed hazardous alcohol use or did not discuss the relationship between TBI and alcohol use.

    SEARCH RESULTS: The search resulted in 196 articles for initial examination. Of those, 155 were excluded and 42 were included. Eight review papers about alcohol use after TBI published from 2009 to 2023 were also examined, which provided foundational and additional background information on publications from 1990 to 2021.

    DISCUSSION AND CONCLUSIONS: This review discusses mechanisms that contribute to negative outcomes after mTBI and hazardous alcohol use and to the development of AUD after mTBI. These include inflammation and immune signaling, neuroendocrine alterations, oxidative stress, neurodegeneration, dopamine signaling, and behavioral impairments. Although current literature on the role of the gut-microbiome axis in this context is limited, this topic is also explored.

    There has been significant research on the biological changes that occur after mTBI and on which mechanisms may precede development of AUD; however, few studies have directly measured the outcomes of alcohol use after mTBI in the same experiment. Future preclinical and clinical research that concurrently studies alcohol use and mTBI could help establish causality for the complex relationship between trauma and alcohol use. Improved knowledge could help identify preventative measures and treatment options to improve quality of life for individuals who experience mTBI and hazardous alcohol use.

    Key Takeaways

    • Mild traumatic brain injury (mTBI) can result in behavioral and physiological symptoms that develop acutely and persist for years after the initial injury, including increased hazardous alcohol use.
    • Neuroinflammation, neurodegeneration, neuroendocrine alterations, aberrant dopamine signaling, and deficits in executive function and reward-processing may contribute to the mechanisms by which TBI and hazardous alcohol use synergistically lead to negative chronic outcomes.
    • Future holistic research looking at biological and behavioral changes that includes females and older subjects could help clarify the relationship between TBI and alcohol.

    Introduction

    Traumatic brain injury (TBI) and alcohol use disorder (AUD) are both public health issues, and their high co-occurrence is a pressing concern for the affected individuals, researchers, clinicians, and policymakers.1 Approximately one-third of individuals who have history of TBI are diagnosed with AUD after injury, and 33% to 75% of individuals with AUD have a history of TBI.2-5 TBIs are classified as “mild,” “moderate,” and “severe,” which corresponds to scores of 13 to 15, 9 to 12, and 3 to 8, respectively, on the Glasgow Coma Scale. Mild TBI (mTBI) can also be called a concussion, and the terms are often used interchangeably. mTBI has been estimated to represent nearly 75% of all TBI diagnoses.3,6 For people who regularly consume alcohol, consumption sharply declines in the month following a TBI diagnosis across all injury severities. Individuals with mTBI tend to resume regular alcohol consumption sooner after injury (generally within 6 to 12 months) and reach moderate to heavy levels of alcohol consumption sooner than individuals with moderate to severe TBI.7 (The Dietary Guidelines for Americans 2020-2025 defines moderate drinking as two drinks or less per day for men and one drink or less per day for women, and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines heavy drinking as five or more drinks per day or 15 or more drinks per week for males and four drinks or more per day or eight or more drinks per week for females.8) This circumstance may be in part because individuals who are diagnosed with mTBI are unlikely to spend time under medical care, whereas people with moderate and severe TBI often have prolonged hospital stays.

    Because there is a lack of publications regarding how hazardous alcohol use influences outcomes after moderate to severe TBI, the focus of this review will be on mTBI—although additional research on moderate to severe TBI will improve overall understanding of neurological and peripheral interactions with alcohol. Hazardous drinking is defined as any quantity or pattern of alcohol consumption that places a person at risk for physical and/or psychological harm, which includes (but is not limited to) all-cause mortality, stroke, cancer, cardiovascular disease, hypertension, traumatic injuries, adverse alcohol-drug interactions, and impaired social and occupational functioning.9 Hazardous drinking encompasses the NIAAA definitions of either heavy drinking or binge drinking (five or more drinks for males and four or more drinks for females in a period of 2 hours), or a score of eight or more on the Alcohol Use Disorders Identification Test (AUDIT).10 Any subsequent descriptions of “hazardous alcohol use” will align with this definition, including the criteria for binge or heavy drinking, unless otherwise stated.

    Despite the label of “mild,” mTBI can result in behavioral and physiological symptoms that develop acutely and persist for years after the initial injury.11-16 Further, individuals with AUD and a history of mTBI generally have worse outcomes, such as more severe symptoms, decreased quality of life, and less responsiveness to treatment.17-19 Due to the high rate of comorbid AUD and mTBI in the general population and the associated costs to individuals, their loved ones, and society, research on this topic is important to identify opportunities for intervention.

    This review does not attempt to answer the question whether mTBI results in the development of AUD (see Olsen and Corrigan20 for a discussion on this topic), but rather discusses the mechanistic changes that occur with hazardous drinking following an mTBI that may worsen chronic outcomes and leave an individual susceptible to developing AUD. The review covers six broad categories of biological mechanisms (inflammation and immune signaling, oxidative stress, local cell death and loss of proteostasis, global loss of white and gray matter volume, neuroendocrine alterations, and dopamine signaling) and various behaviors related to executive functioning (cognitive and reward processing deficits, disinhibition, impulsivity, and affect).

    Various subsets of the population that experience mTBI and AUD at higher rates are discussed, and only adult populations (age 18 and older) are included (the strong relationship between AUD and prior experience of TBI in adolescence has been previously reviewed).21,22 Additionally, because this review discusses chronic outcomes after mTBI and mechanisms that influence the onset of AUD, papers about individuals with preexisting AUD and/or TBIs that occurred while intoxicated are not included. It is beyond the purview of this review to compare the biomechanical forces and pathological progression of different types of injury modalities leading to mTBI (e.g., blunt impact, penetrating, blast, or rotational),23 but it is important to note that blast exposure is a whole-body injury and often results in polytrauma as a primary diagnosis rather than only mTBI. Like other modalities, blast TBI can result from one acute exposure; however, recent attention also has been focused on understanding how blast TBI can occur in response to multiple subconcussive low-level blasts from the use of high-powered artillery during military training. Peripheral impacts of traumatic injuries are especially relevant when discussing comorbid alcohol use, because alcohol affects multiple systems throughout the body. Although focal mTBIs also affect the body beyond the brain, it may be prudent to specifically explore blast-induced mTBI and alcohol interactions in the future because of the diffuse nature of the injury.

    This review provides an overview of studies published from March 2021 to December 2024 and how these new findings fit into the existing literature. Limitations of the surveyed papers and the interpretations in this review are discussed, as well as gaps in the literature and future research avenues of interest for improving outcomes.

    Search Methods

    This review was conducted by searching “alcohol, traumatic brain injury, TBI” in PubMed, Google Scholar, and Medline databases. Database searches took place during October and December 2024, with the last search on December 16, 2024. No unpublished results or preprints were included. Only articles in English were reviewed, including articles from five continents (North America, Europe, Asia, Africa, and Australia). Titles, abstracts, and methods of all articles were read to determine relevance, then the full texts of articles that met the inclusion criteria were obtained. The search included articles published after March 2021, and previously published reviews on this topic were consulted to identify relevant papers published before 2021. Articles were excluded if they only discussed (1) moderate/severe TBI (9 articles), (2) adolescent populations or TBI during adolescence (11 articles), (3) populations with a history of AUD before TBI (14 articles), (4) acute outcomes that occurred within 2 weeks after TBI (seven articles), or (5) prevalence or effects of TBI incurred while intoxicated (62 articles). Also excluded were papers that did not specify if TBI preceded or followed hazardous alcohol use (five articles) or that did not discuss the relationship between TBI and alcohol use (46 articles).

    Results of the Literature Search

    The search identified 196 articles for initial examination. Of those, 154 were excluded for the reasons described above and 42 were included in the review. Six of the papers described preclinical research, 34 covered human data, and two included both preclinical and clinical results. Eight additional review papers about alcohol use after TBI published between 2009 and 2023 were reviewed, which provided foundational and further background information for publications from 1990 to 2021.

    Results of the Reviewed Studies

    Rates of AUD and Psychiatric Disorders After mTBI

    Patterns of alcohol use after mTBI varied based on a number of demographic factors. Younger age, not being in a relationship, previous alcohol use, and intoxication at the time of injury were associated with higher rates of hazardous alcohol use post injury.24,25 Military personnel and contact-sport athletes experience TBIs and alcohol use at higher levels than the general population; therefore, extra attention was given to these populations in this review.7 Of the reviewed studies published between 2021 and 2024 that investigated the relationship between TBI and subsequent alcohol use patterns, eight focused on military populations (service members and veterans), six on contact-sport athletes, and nine on the general population.

    Historically, research has found that hazardous alcohol use is more common in military populations with a history of mTBI compared to those in the general population with an mTBI diagnosis.26 Previous research has also shown that hazardous alcohol use is more common among veterans with mTBI than those without mTBI, and the rate is even higher for those with comorbid mTBI and post-traumatic stress disorder (PTSD).27 Recent findings published between 2021 and 2024 about alcohol use after mTBI, however, were mixed. A handful of studies found similar rates of alcohol consumption and AUD between veterans with and without mTBI, although PTSD, depression, and poor cognitive function were still observed after mTBI.28-30 In contrast, multiple papers confirmed previous findings of higher levels of alcohol consumption in veterans with mTBI compared to those without.31-36 Brenner et al. found that service members with a history of mTBI had a 22% higher increase in AUD from preinjury levels compared to those without mTBI.32 Steffen-Allen et al. observed a peak in alcohol consumption at 2 years after mTBI at 4.8 drinks per week on average (compared to 2.3 drinks per week preinjury), before dropping to 3.5 drinks per week at 2 to 5 years after mTBI.36 The probability of binge drinking (i.e., consuming five or more drinks for men, four or more for women, on any one occasion) increased from 14% preinjury to approximately 30% for the 1 to 5 years after mTBI.

    Contact-sport athletes (football, boxing, hockey, soccer, rugby) are also at higher risk for mTBI than the general population.37 Because of the length of their participation in sport, the risk for repetitive mTBI and cumulative effects of subconcussive head impacts are a concern specifically for collegiate and professional athletes.38 There is also a pervasive culture of alcohol and substance use in many sports, which exposes individuals to hazardous drinking starting in high school and potentially continuing through retirement.39 These two factors, along with recent attention to the long-term psychological and cognitive health of contact-sport athletes, have motivated research regarding the association between mTBI and alcohol use in current and former athletes.39 Recent findings regarding this association in contact-sport athletes have been mixed. Three papers surveying retired professional football, hockey, and rugby players, respectively, did not find a significant association between number of concussions and alcohol use.37-39 The results differed for collegiate athletes: not only was mTBI history predictive of alcohol use, but alcohol use in the 4 weeks after sustaining a concussion prolonged recovery time.17,40 A study of former collegiate football players did not specifically report previous TBI history but determined a higher prevalence of cognitive impairment, headaches, and alcohol use compared to the general male population.41 It is possible that these opposing results between retired professional athletes and collegiate athletes is reflective of the role that age plays in influencing outcomes after mTBI and with alcohol use.

    The articles identified in the literature search covered a range of subpopulations, including different nationalities (e.g., individuals from Canada, Switzerland, China, and the United States); specific racial or ethnic groups, such as Hispanics; and rural versus urban populations. Although nuances across the recently published studies existed, there was general agreement that alcohol consumption increased after mTBI.42,43 Multiple studies also found significant increases in the rates of other negative outcomes after mTBI in addition to alcohol use, including depression, aggression-hostility, risk of developing dementia, and poor general mental health.44-48

    Because of the heterogeneity in how mTBI manifests from person to person, one cannot say that mTBI exposure increases hazardous alcohol use for every individual. However, many previous and current studies have supported this association, and for a subset of individuals, mTBI symptoms clearly linger for years after the initial injury. Determining the biological changes that occur after mTBI and that interact with hazardous drinking to worsen outcomes and contribute to the development of AUD will be critical in understanding this complex relationship and identifying effective interventions.

    Biological Mechanisms Connecting TBI and AUD

    Multiple distinct mechanistic changes occur after mTBI that are also associated with hazardous drinking. However, although clinical studies can measure biological and behavioral changes and their association with alcohol use and mTBI, it is difficult to prove causality and the degree of contribution in human subjects. Preclinical studies allow for deeper interrogation and play a significant role in understanding how biological outcomes may mediate the connection between mTBI and AUD. Translationally relevant animal models include the fluid-percussion and closed-head weight-drop models for impact TBI, the CHIMERA model for rotational TBI, and blast exposures for blast TBI. The following sections discuss various mechanisms in the context of preclinical and clinical work. The six mechanisms of interest broadly defined here are not exhaustive but are based on the results of the literature search. They represent a holistic view of the plausible substrates that influence chronic outcomes and post-injury alcohol consumption. An in-depth explanation of each mechanism is outside the scope of this review, and readers are referred to the referenced papers for more detailed information on each topic.

    Inflammation and immune signaling

    Both mTBI and alcohol use can lead to increased inflammation and immune signaling. Immune cascades include the release of damage-associated molecular patterns (DAMPs); activation of Toll-like receptor 4 (TLR4), which recognizes DAMPs and then mediates downstream immune responses; upregulation of proinflammatory cytokines and chemokines, such as interleukin-1-beta (IL-1beta), IL-6, and tumor necrosis factor-alpha (TNF-alpha); the shift from healthy microglia and astrocytes to a primed or reactive state; disruption of the blood-brain barrier; cell death; and neurodegeneration.20,49-55 Although an acute inflammatory response is crucial for recovery and is initially beneficial to an organism after injury, the transition to chronic inflammation can eventually be detrimental.56 A state of chronic inflammation predisposes the system toward hyperreactivity, where a minor immune challenge can lead to an exaggerated response. This drives the organism further from homeostasis, leading to biological, cognitive, and behavioral dysfunction.57,58

    It is not fully understood how the overlapping immune cascades interact after mTBI and subsequent alcohol consumption. In a recent study, mice that were fed an ethanol liquid diet after fluid percussion mTBI (which involves applying a brief fluid pressure pulse onto the brain through a hole in the skull) had elevated immune-related factors compared to control animals when treated with either alcohol or mTBI; levels of these factors were even higher in the mTBI + alcohol condition. This pattern held true for matrix metalloproteinases 2 and 9 (MMP2, MMP9); the key transcription factor nuclear factor-kappa B (NF-kappaB); the proinflammatory cytokines transforming growth factor beta-1 (TGFbeta-1), IL-1beta, TNF-alpha; the marker for microglia expression, ionized calcium-binding adapter molecule 1 (Iba1); and the marker for astrocyte expression, glial fibrillary acidic protein (GFAP).59 These results suggest that alcohol consumption and mTBI synergistically contribute to inflammatory outcomes and downstream immune signaling. Investigators also hypothesized that neuroinflammation itself may increase alcohol consumption through downstream effects, such as structural neurodegeneration and altered function in areas of the reward pathway (e.g., prefrontal cortex, ventral tegmental area, and the nucleus accumbens).60 No recent studies measured immunologic biomarkers in humans; however, one study suggested that anti-inflammatory diets (e.g., ketogenic, Mediterranean, or MIND diets) and supplementation with omega-3 polyunsaturated fatty acids and vitamin D may provide therapeutic benefits to individuals with mTBI, whereas alcohol consumption with its proinflammatory effects may be detrimental to recovery.61 This is likely because chronic inflammation and upregulated cytokine levels are associated with adverse biological and psychological outcomes after mTBI; thus, any additional sources of inflammation after injury are hypothesized to have a negative influence on overall health.62-64

    The role of the microbiota in the gut and the gut–brain axis in alcohol use after mTBI is still underresearched but is a mechanism of interest and deserves further exploration. Interest in how the gut–brain axis is impacted by mTBI has only developed in the past couple of decades.49,65,66 Despite a fairly extensive literature on how alcohol affects the microbiome and gut–brain axis, it is not known whether changes in the microbiome directly drive alcohol use.67-69 Regardless, the gut–brain axis and its interaction with the immune system is an interesting area of emerging research. Some individuals with mTBI develop gastrointestinal symptoms, and AUD has long been associated with negative gastrointestinal outcomes.70,71 More recent work is beginning to uncover more specific changes in the gut–brain axis associated with mTBI and AUD, including altered mucosal permeability, changes in bacterial composition (dysbiosis) and movement (dysmotility), changes in metabolic pathways, and hormone dysregulation originating from the gut.58,67,72,73

    Oxidative stress

    Another mechanism relevant to the pathological progression of mTBI and AUD is oxidative and nitrosative stress. Oxidative and nitrosative stress occurs when there is an excess of free radicals, called reactive oxygen species (ROS) and reactive nitrogen species (RNS), respectively. When interacting with other molecules in the cells, these free radicals can then form toxic compounds. Free radicals are normally contained and neutralized by antioxidants, but an imbalance between radicals and antioxidants can lead to myriad biochemical disruptions, including lipid peroxidation, protein modification, mitochondrial dysfunction, impairment of the blood–brain barrier through loosening of vasculature and downregulation of tight junction proteins, induction of apoptosis and inflammation, and ultimately accelerated aging and neurodegeneration.74-78 It is hypothesized that oxidative stress occurs in TBI because the force of the impact or pressure wave induces mitochondrial and enzymatic activity, thus increasing ROS production. Alcohol use also promotes ROS formation: alcohol metabolism creates the byproducts H2O2 and acetaldehyde, and the interaction of H2O2 with copper or iron produces ROS.

    Two recent studies quantified the expression of oxidative and nitrosative stress-inducing enzymes and markers of oxidative/nitrosative damage after mTBI and alcohol consumption in mice. The enzymes included nicotinamide adenine dinucleotide phosphate oxidase 1 (NOX1) and inducible nitric oxide synthase (iNOS), and the markers of damage included acrolein, 4-hydroxynonenal (4HNE), and 3-nitrotyrosine (3NT). Abdul-Muneer et al. observed elevated NOX1, iNOS, 4HNE, and 3NT in alcohol-only and mTBI-only groups, and further exacerbated levels in the mTBI + alcohol group.59 This suggests that oxidative stress may be a central mechanism that triggers other pathways of inflammation and neurodegeneration. Zhang et al. found elevated acrolein levels in multiple brain regions related to memory and anxiety in the mTBI + alcohol group only.79 The authors hypothesized that it was specifically the synergistic interaction of alcohol consumption after mTBI that damaged biochemical and cellular processes and induced the vulnerable state. Oxidative stress clearly is an important mechanism for AUD and mTBI, although more research is needed to interrogate the causality and progression of oxidative stress after mTBI and how it may contribute to increased alcohol consumption.

    Neurodegeneration—Local cell death and loss of proteostasis

    There is extensive literature on the role of AUD and TBI in development of dementia and neurodegeneration. Although results vary to some degree across clinical studies, and more standardized research is needed, both hazardous drinking and TBI are currently considered established risk factors for dementia and neurodegeneration, particularly if they occur during older age.57,80 Neurodegeneration can manifest as local cell death, which occurs acutely after injury, and as loss of proteostasis, which sometimes begins in the days to weeks after mTBI, but typically is not pathologically relevant until much later in life. Proteostasis is the homeostatic state of normal protein structure, expression, and functioning, and loss of proteostasis in amyloid-beta, tau, TAR DNA-binding protein 43 (TDP-43), alpha-synuclein, and other proteins can result in development of Alzheimer’s disease and related dementias.81 None of the clinical studies surveyed for this review found that alcohol consumption increased neurodegenerative markers (e.g., ISGylation, interferon beta, TDP-43, phosphorylated tau, or clinical cognitive assessment), whereas mTBI exposure did.82,83

    Research conducted in a mouse model found that multiple measures of neurodegeneration (i.e., A-beta-42, phosphorylated tau, and markers of neuronal damage and apoptosis) were exacerbated by mTBI and alcohol together, compared with each alone or with control groups.59 In a drosophila model, researchers used a loss-of-function mutant in the dTau (drosophila Tau) gene, which is 44% identical and 66% similar to human Tau and models dysfunctional tau expression. mTBI and dTau loss of function each separately resulted in greater ethanol sensitivity, and there was an additive effect when mTBI was induced in the dTau loss-of-function mutant.84 Changes in ethanol sensitivity can result in changes in alcohol intake patterns, physiological response to alcohol, or both.84 Thus, TBI history and tau status likely play a role in alcohol use patterns. Another study investigated the role of a variant of the apolipoprotein E (APOE4) gene in mTBI and alcohol consumption (APOE4 is the strongest known genetic risk factor for sporadic Alzheimer’s disease).85 The investigation was based on evidence that individuals with the APOE4 gene who regularly consumed alcohol, especially females, were more vulnerable to cognitive impairment.85 The preclinical data indeed found an mTBI- and genotype-dependent effect on alcohol consumption, alcohol motivation, and risk-seeking behaviors. These studies demonstrate that genetic variants may help explain some of the heterogeneity in how mTBI and alcohol use influence the progression of neurodegeneration.

    Neurodegeneration—Global loss of white and gray matter volume

    More advanced stages of neurodegeneration and widespread cell death result in loss of white and gray matter volume. Gray matter is found on the surface of the brain and predominantly consists of cell bodies, whereas white matter is found in deeper brain structures and contains myelinated axons. The stereotypical temporal progression of tissue loss seen in normal aging differs from the pathological tissue loss seen after TBI, AUD, or in neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, or frontotemporal dementia.86-88 Frontal and limbic structures are sensitive to degeneration after AUD or mTBI, which is in contrast to normal aging processes where limbic structures are typically spared.55

    Measuring white and gray matter volume is readily done in humans but is far less common in mouse models due to their small size and lack of meaningful resolution. Magnetic resonance imaging (MRI) in a population of U.S. military service members and veterans was used to compare a calculated predicted brain age and chronological brain age.86 In males, deployment-related mTBI was associated with higher predicted brain age, whereas in females, a history of nondeployment mTBI was associated with older-than-expected brain age. Further analysis of the male participants showed that alcohol use was also associated with increased predicted brain age.

    Diffusion-weighted MRI (dMRI) is a method that measures density of tissue, reflecting microstructural integrity and strength of axonal-dendritic connections. Rojczyk et al. performed dMRI in a cohort of veterans diagnosed with PTSD, substance use disorder, mTBI, or mood disorder. They found that veterans diagnosed with AUD or mTBI were more likely to engage in intimate partner violence, and those with higher psychological aggression had greater tissue density in the right amygdala-hippocampus complex.89 The study did not directly measure alterations in microstructural gray matter tissue integrity and timing of mTBI or alcohol use in this cohort of veterans; therefore, no definitive conclusions about causality can be made.

    Both of the aforementioned studies, like a majority in the literature, measured gray and white matter volume after AUD or mTBI diagnosis. However, preexisting reductions in gray matter volume in regions related to decision-making, emotion, and reward processing could be a risk factor for hazardous alcohol consumption or mTBI.90 This interpretation may be harder to confirm in clinical studies due to limitations in establishing causality but could improve understanding about how tissue volume influences behavior.

    Neuroendocrine alterations

    The neuroendocrine system is vast and complex and is influenced by many lifestyle and environmental factors. It is responsible for the regulation of homeostatic and adaptive physiological processes and functions through hormone secretion and signaling mainly from the hypothalamus, pituitary gland, and adrenal glands. This hypothalamic-pituitary-adrenal axis is responsible for the stress response after physical or psychological challenges and trauma. One of the primary hormones involved in the stress response is cortisol (known as corticosterone in rodent models). No papers surveyed for this review specifically measured cortisol or corticosterone, but other preclinical, clinical, and review papers found that cortisol/corticosterone dynamics are complicated. The hormones often show elevated levels in response to acute stress but blunted response after chronic stress; there is also a strong circadian influence.91-95

    A recent study quantified both hormones from the pituitary gland (i.e., follicle-stimulating hormone, luteinizing hormone, adrenocorticotropic hormone, and thyroid-stimulating hormone) and hormones from pituitary target organs (i.e., testosterone, cortisol, and free thyroxine) after mTBI and alcohol consumption to determine pituitary function.96 Twelve months after mTBI, 16% of individuals had developed pituitary deficiency. The affected population was more likely to be younger and female, but there were no associations between pituitary deficiency and injury modality or complications. Individuals with mTBI who consumed alcohol at low-risk or heavy-drinking levels were less likely to develop pituitary dysfunction, whereas those with mTBI who did not consume alcohol regularly had increased risk.

    Corticotropin-releasing factor (CRF) is a neuropeptide that is released from the hypothalamus and then acts upon the pituitary; it is often studied in relation to trauma and/or alcohol use. In a recent study, lower levels of CRF were able to distinguish individuals with PTSD from those with PTSD and mTBI, which often occur together.97 The PTSD group was then split into individuals with AUD and those without. The level of CRF did not differ significantly between these groups, although the PTSD + AUD group had less variability in their CRF levels than the PTSD without AUD group. Taken together, this suggests that although dysregulation of CRF is not specific to mTBI, the correlation with PTSD means that it may be more relevant for the psychological aspect of trauma and could be connected to alcohol use in that way.

    The dynorphin/kappa opioid receptor (KOR) system plays an important role in the neuroendocrine system and stress response through its expression across the HPA axis and interactions with CRF.98 The dynorphin/KOR system independently plays roles in mTBI and alcohol use, and is hypothesized to be a potential link between the two.99 Although the entire signaling cascade is more complicated than can be fully appreciated here,100 it is generally thought that dynorphin and KOR activity increases after mTBI, leading to a dysphoric state.101 Dynorphin/KOR activation causes decreased tonic dopamine levels, thereby disrupting reward pathways and behaviors, promoting negative affect/anxiety-like behaviors, and enhancing disinhibition.102-106 The resulting state mediated by the dynorphin/KOR system affects neurotransmitters, neuropeptides, excitation-inhibition balance, and inflammation, which is hypothesized to “neurochemically prime” the brain toward hazardous alcohol and substance use behaviors.60 

    Brain-derived neurotrophic factor (BDNF) also helps to regulate the neuroendocrine system and the stress response. BDNF has neuroprotective properties and is involved in neuroplasticity, neurogenesis, synaptogenesis, and cell survival. BDNF signaling is affected by stress exposure and is implicated in many mood disorders in addition to AUD and mTBI.107,108 BDNF has been linked to mTBI because of its role in the repair and regeneration of neurons, and different genetic variations of BDNF may influence outcomes after mTBI.109-111 There also has been interest in how alcohol consumption affects BDNF and its role in neuroplasticity and how BDNF signaling may affect alcohol consumption.112 Based on previous research, it can be hypothesized that if BDNF normally plays a role in regulating the moderation of alcohol consumption, then an mTBI exposure that disrupts BDNF signaling may lead to escalated alcohol intake or preference.113 A recent paper found that BDNF levels predicted development of PTSD after mTBI only in individuals who had consumed any level of alcohol in the past year, further implicating BDNF in the synergistic interactions of mTBI and alcohol use.114

    Another component of the neuroendocrine system is the endocannabinoid (eCB) system, which regulates many functions in the body and plays a role in homeostasis. Downstream mechanisms affected by eCB signaling include neuroinflammatory effects, blood–brain barrier permeability, cerebrovascular modulation, glutamate excitotoxicity, and neuroplasticity. Both alcohol and mTBI dysregulate eCB functioning.115-117 The eCB system is a potential target for new therapies (for mTBI, AUD, and number of other conditions) because it exerts neuroprotective effects in response to detrimental stimuli.118 The drug JZL184 (4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl) (hydroxy)methyl]piperidine-1-carboxylate) inhibits degradation of eCBs, effectively prolonging their activity and function. Treatment of fluid percussion mTBI with JZL184 improved neurological and behavioral outcomes, blood–brain barrier integrity, and glial activation and decreased alcohol motivation in male rats.119-121 A follow-up study found that a repetitive closed-head weight drop model of mTBI (which involves dropping a small weight or rod from above the skull to produce a focal cerebral contusion as well as diffuse injury mechanisms) induced higher alcohol consumption in female but not male adult rats, and increased anxiety in male but not female adult rats.122 JZL184 did not affect alcohol behavior in either sex; however, in contrast to the previous research, it increased anxiety-like behavior in male rats at 1 week post mTBI. The researchers hypothesized this could be due to the dose level or specific timing of drug administration, supporting the idea that eCB signaling is dynamic and can have differential effects.

    Dopamine signaling

    Many problematic behavioral changes that are associated with mTBI and/or AUD concern behaviors that are typically associated with dopamine signaling. Biochemically, alcohol has rewarding properties that directly affect dopamine signaling and are implicated in motivated behavior.123 The literature about alterations in neurotransmitter signaling, especially dopamine signaling, that occur after mTBI and influence alcohol drinking behaviors is primarily based on preclinical models (for specific studies, see the review articles by Weil et al.,55 Merkel et al.,60 and Gallant and Good124). It is difficult to study dopamine dynamics in humans. Nevertheless, people with TBI are sometimes prescribed drugs that increase dopamine signaling (e.g., methylphenidate, amantadine, bromocriptine) due to their effectiveness in treating behavioral symptoms, including working memory, attention, mental fatigue, cognitive processing speed, social functioning, and depression.125,126

    It is thought that corticostriatal dopamine levels increase acutely after mTBI, resulting in a hyperdopaminergic state. At some point between 24 hours and 2 weeks after injury, corticostriatal regions then transition to a hypodopaminergic state.1,60,124 In contrast, evoked dopamine responses in the nucleus accumbens are increased at both 4 to 7 days and 30 days after (blast) mTBI.127 There is also a bidirectional relationship between dopamine signaling and inflammation as the release of dopamine may increase inflammation but the availability of dopamine precursors is reduced after an inflammatory response.55 Further, both the primary phase (impact forces) and the secondary phase (oxidative stress) of TBI can damage dopaminergic neurons. Dopaminergic white-matter tracts, such as the mesocorticolimbic pathway, are particularly affected by the stretching and shearing that occurs during some injury modalities.128,129 One recently published study found that male, but not female, mice showed reduced numbers of cells expressing the dopamine receptor D2 in various areas of the hippocampus (i.e., dentate gyrus, lacunosum moleculare, and CA3 areas) 4 weeks after fluid percussion TBI.130 This confirms previous findings of a chronic hypodopaminergic state after TBI, and although the hippocampus is not part of the corticostriatal or mesolimbic dopamine pathways, it has been strongly implicated in memory and is one of the first areas affected by neurodegeneration.

    Alcohol directly acts on the mesolimbic dopamine system, also known as the reward pathway. Alcohol consumption causes a release of dopamine in the nucleus accumbens, and other alcohol-related behaviors—such as alcohol seeking, craving, and withdrawal—are hypothesized to have biological substrates in the mesolimbic pathway and to affect dopamine signaling (for reviews of alcohol’s interactions with the dopamine system, see Siciliano et al. 2018,123 Söderpalm and Ericson 2024,131 and Wise and Jordan 2021132). Because disruptions in dopamine signaling after mTBI have an effect on reward circuitry, alcohol-related behaviors likely would also be affected. Moreover, aberrant dopamine transmission in brain regions, such as the prefrontal cortex affect cognition and decision-making, which can also impact hazardous drinking.133

    Behavioral Impairments Connecting TBI and AUD

    The literature clearly indicates that behavioral changes after TBI significantly contribute to decreased quality of life post-injury.16,31,134-137 Physiological changes after injury are undoubtedly important and contribute to disease progression, but underlying biological changes can go unnoticed in daily life. Impairments in cognition, executive functioning, and mood or alterations in decision-making, irritability, and impulsivity may be more apparently detrimental and easier for others to notice. This section reviews the behavioral changes that are common after TBI, the relationship with hazardous alcohol consumption, and how they may lead to the development of AUD.

    Cognitive and reward processing deficits

    Cognitive deficits after TBI are common and include problems with attention, memory, and executive function (e.g., planning, organization, decision-making, and goal-oriented behaviors).138-140 Behavioral symptoms sometimes appear immediately and persist chronically; in other cases, they may not develop until years after the initial injury. Dopamine signaling in brain regions such as the prefrontal cortex, striatum, hippocampus, thalamus, and others plays an important role in cognition and reward processing.141 Many hypothetical models attempting to explain a scientific basis for addiction are based on impairments in decision-making, goal-oriented behavior, and reward-processing (e.g., incentive salience, incentive sensitization, reward-deficiency, and ambivalence).142-147 These behaviors sometimes develop after mTBI, and as described below, they may play a role in driving negative outcomes and hazardous drinking after injury.

    Following TBI, individuals may give higher reward value to alcohol than they did before the injury.124 On the one hand, this change may have a biological basis in disrupted reward circuitry in the brain or biochemical changes that affect the rewarding properties of alcohol. On the other hand, it may in part be due to psychosocial factors, such as desire for social cohesion, maladaptive coping mechanisms, and alcohol’s ability to reduce anxiety and negative mood (which will be discussed further in the next section). Individuals with TBI may also have issues with anticipating and weighing future consequences, which can lead to hazardous drinking behaviors.55 Improper appraisal of the potential benefits and/or costs of a decision can lead to a suboptimal decision, which is seen in individuals with TBI during clinical tasks.148 Impairments in executive functioning may also increase the prevalence or severity of alcohol use by impacting efficacy of therapeutic interventions. For example, difficulty with attention, planning, and organization may interfere with the ability to start or continue treatment. Furthermore, aspects of treatment that utilize self-reflection or critical thinking may be more difficult after TBI, such that individuals with TBI may not respond to typical treatment strategies and require other interventions.1

    A study of nearly 200,000 veterans found that the greatest risk factor for receiving a diagnosis of dementia or mild cognitive impairment was history of mild or moderate TBI, and that either a history of high alcohol use or current high alcohol use was also associated with cognitive deficits when controlling for previous TBI.34 In this study, high alcohol use was defined as a score of 6 or higher on the AUDIT-C. A smaller study of veterans with substance use disorder did not find an association between TBI history and cognitive deficits but did find that higher impulsivity and lower cognitive performance were correlated with higher health care costs within the VA Hospital system.149 The study did not report the specific classification of TBI for each participant, but overall the study population was described as reporting a low severity of TBI. These results indicate that individuals experiencing behavioral impairments may have worse outcomes and also suggest an opportunity for a point of intervention that may improve health care outcomes and costs.

    In a sample of civilians in Uganda, 56% of individuals with TBI reported cognitive deficits. Severity of TBI (mild/moderate/severe) was not reported; however, loss of consciousness was associated with a higher risk of cognitive deficits, indicating some relationship between TBI severity and cognitive impairment.150 Alcohol use appeared to be protective against cognitive impairment in this study. Several other studies also have proposed that light alcohol consumption may have no effect or potentially even protective effects on cognitive function, although results are mixed.151-153 However, there are no recommended safe drinking levels, and many health organizations recommend limiting consumption due to the negative effects of chronic heavy consumption, binge drinking, and AUD.154,155

    Impulsivity, disinhibition, and affect

    Another common behavioral phenotype that is observed after mTBI is impulsivity, which is related to the personality trait of disinhibition.127,156 Impulsivity refers to acting without thinking and without regard for consequences (i.e., it represents a specific behavioral expression), whereas disinhibition is defined as a lack of control over unwanted behaviors and poor self-regulation (i.e., it represents a stable personality trait characterized by aggressive, irritable, and risk-taking behaviors in addition to impulsivity).157 Disinhibition and impulsivity are predictive of AUD even in non-mTBI populations, and it has been hypothesized that aberrant dopaminergic signaling (as seen in mTBI) plays a role in how disinhibitory behaviors influence the onset and development of AUD.55,124,158,159 Two recent clinical studies of civilian populations indeed found that those with a history of mTBI had the highest endorsement of impulsivity, irritability, anger expression, and antisocial behavior; however, only one of the studies observed higher rates of AUD.137 Alcohol use after mTBI in civilian populations tends to be more varied than in veterans or contact sport athletes, and the study that did not find a relationship only consisted of 368 participants total.160 

    Affect and mood disorders may also contribute to increased alcohol consumption after mTBI. Decreased mood and increased anxiety are seen in approximately 25% to 50% of individuals who have experienced TBI, and mood disorders are independently associated with increased rates of alcohol use.134,161 One hypothesis is that alcohol can be used as a maladaptive coping strategy to avoid negative emotions, thoughts, and feelings, all of which may increase after mTBI.162 Further, individuals who use alcohol to avoid negative states tend to show more hazardous and binge-like consumption patterns; conversely, those who drink for enhancement of positive states and social reasons tend to consume alcohol more moderately.55,163 Although an in-depth discussion of PTSD is outside the scope of this article, it should be mentioned that mTBI and PTSD are highly comorbid, as are PTSD and AUD. Research on the mechanisms and behaviors specifically relevant to PTSD has been done, although additional studies can help identify effective treatments.2,11,54,164 

    Discussion

    Conclusions of the Review

    Decades of research have been conducted on either mTBI or alcohol use alone. However, preclinical and clinical research only started to focus on the onset of AUD and the negative outcomes associated with hazardous drinking after mTBI in the past 15 years, and particularly in the last decade. Further research in this area that builds upon the existing literature may help to better understand the progression of symptoms and mechanistic changes that occur with alcohol use after mTBI, preexisting factors that influence this progression, and possible interventions that may prevent hazardous drinking patterns and negative chronic outcomes.

    Perhaps the most striking conclusion from this review is the heterogeneity in injuries and outcomes among individuals who experienced mTBI. Many individuals report no apparent long-lasting symptoms after injury, whereas others experience persistent symptoms for months to years after mTBI. In yet another subset, changes in behavioral and biological systems and functions go unnoticed until they manifest years after mTBI.

    The stereotypical acute injury mechanisms after mTBI include oxidative stress, cell death, and an inflammatory response. Over time, this progresses into some combination of chronic inflammation, neuroendocrine alterations that affect a wide array of systems across the body, changes in dopamine signaling, and global gray- and white-matter loss. These biological changes manifest in various cognitive and neuropsychiatric behavioral deficits after injury, and people with mTBI have a higher risk for mild cognitive impairment or dementia. Although most studies—this review included—discuss all of these mechanisms separately, physiological and behavioral changes after mTBI occur in parallel as well as synergistically. These impairments not only have the potential to contribute to increased hazardous alcohol consumption, but also to interact with the cascade of effects resulting from alcohol consumption. The synergistic interaction of biological mechanisms means that people with mTBI who consume alcohol may experience more, and more severe, impairments than their uninjured peers who use alcohol. Military populations, contact-sport athletes, and adolescents are especially vulnerable to the impacts of mTBI and often see worse outcomes. Potential explanations include environmental factors that may be more prevalent for service members than the civilian population, the repetitive nature of injuries in athletes, and the continued development of neurological and peripheral systems in adolescence.

    Limitations

    This review is limited in several ways. The clinical papers identified include a wide range of populations, age ranges, time frames after injury, and injury modalities that affect outcomes. For example, blast and rotational injuries likely result in different downstream mechanistic changes than do penetrating or blunt force injuries. While the variety of papers reflect the heterogeneity of how mTBIs and hazardous alcohol use manifest in individuals across many populations and scenarios, the broad nature of the search prevented in-depth discussion of all relevant populations and mechanistic impairments. Another important consideration is that across populations, TBI exposures are often underreported, especially mTBI. For example, people may not always realize that they received an mTBI; in other cases, accurately reporting symptoms may prevent participation in sports or military activities. Numerous lifestyle factors that can significantly impact outcomes after TBI also were not considered in every study, including sleep, physical activity, diet, social environment, environmental pollutants or toxins, family history, or genetic factors. In clinical studies, details regarding the exact amount and timing of alcohol consumption or the amount of time since injury may not be precise, which could also affect the conclusions that are drawn. Finally, a significant number of individuals who experience TBI are also diagnosed with PTSD. It is difficult to fully understand the separate contributions of TBI and PTSD to the resulting biological and behavioral symptoms (for further discussion of this topic, see Hendrickson et al.11). This review did not separate individuals with only TBI from those with TBI and PTSD unless it was specified in a specific study. 

    The preclinical literature also had some pressing limitations to be addressed in future research. Female subjects were often not included, especially in research involving blast models of TBI. Additionally, there was a paucity of research on how mTBI exposure interacted with alcohol use in older individuals, even though older adults are experiencing TBIs at a higher rate than any other age group and exhibit continually increasing rates of binge drinking.165,166 Perhaps the most important limitation was that there were limited preclinical studies that included mTBI exposure and alcohol access in the same model. A significant proportion of knowledge about mTBI and alcohol interactions has come from evidence obtained in studies of the individual conditions where the outcomes seen after mTBI overlapped with mechanisms seen with hazardous alcohol drinking.

    Future Directions

    To date, there are fewer than 10 published studies in which preclinical subjects were exposed to mTBI and then given access to alcohol in the same cohesive experiment.35,59,79,82,84,85,122 Future research would benefit from this experimental design because it has translational relevance and could improve understanding of the synergistic interactions between mTBI and alcohol more effectively than studying the two conditions in separate subjects and models.

    Greater knowledge about the underlying mechanisms that occur after mTBI and how they influence the onset of AUD could improve how individuals with mTBI are treated across many populations. Basic and translational research would allow for advances in therapies and interventions to improve outcomes at multiple stages of injury progression. Additionally, studies that investigate the interactions across multiple mechanisms could move the field forward. For example, research could examine how oxidative stress leads to gray-matter loss, how inflammation exacerbates aberrant neuroendocrine signaling and hormone release, how changes in the microbiome affect behavior, and similar questions. Future research that looks holistically at both central and peripheral systems and that includes historically understudied populations could make tangible progress in understanding how mTBI drives development of AUD.

    Acknowledgments

    This work was supported by grants from UW NAPE Pilot Program NIDA DA048736 (J.S.), National Institute on Alcohol Abuse and Alcoholism grant F31AA031908 (M.P.), and U.S. Department of Veterans Affairs BLR&D Merit Review Award 1I01BX005582 (A.G.S.). The authors would also like to thank Monica Tschang and Renata Daniels for helpful comments on the manuscript.

    Correspondence

    Address correspondence concerning this article to Abigail G. Schindler, VA Puget Sound Health Care System, S182, 1660 South Columbian Way, Seattle, WA 98108. Email: [email protected]

    Disclosures

    The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U. S. government. The authors have declared no competing financial and nonfinancial interests.

    Publisher's note

    Opinions expressed in contributed articles do not necessarily reflect the views of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health. The U.S. government does not endorse or favor any specific commercial product or commodity. Any trade or proprietary names appearing in Alcohol Research: Current Reviews are used only because they are considered essential in the context of the studies reported herein.

    References

    1. Weil ZM, Corrigan JD, Karelina K. Alcohol use disorder and traumatic brain injury. Alcohol Res. 2018;39(2):171-180.
    2. Jorge RE, Li R, Liu X, et al. Treating alcohol use disorder in U.S. veterans: The role of traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2019;31(4):319-327. doi:10.1176/appi.neuropsych.18110250
    3. Pagulayan KF, Temkin NR, Machamer JE, Dikmen SS. Patterns of alcohol use after traumatic brain injury. J Neurotrauma. 2016;33(14):1390-1396. doi:10.1089/neu.2015.4071
    4. McHugo GJ, Krassenbaum S, Donley S, Corrigan JD, Bogner J, Drake RE. The prevalence of traumatic brain injury among people with co-occurring mental health and substance use disorders. J Head Trauma Rehabil. 2017;32(3):E65-E74. doi:10.1097/HTR.0000000000000249
    5. Lemsky C. Traumatic brain injury and substance use disorders: Making the connections. Addiction Technology Transfer Center Network. Published online October 27, 2021. https://attcnetwork.org/wp-content/uploads/2021/04/TBI-SUD-Toolkit-FINAL-11.05.2021.pdf
    6. Dikmen S, Machamer J, Temkin N. Mild traumatic brain injury: Longitudinal study of cognition, functional status, and post-traumatic symptoms. J Neurotrauma. 2017;34(8):1524-1530. doi:10.1089/neu.2016.4618
    7. Elder GA, Ehrlich ME, Gandy S. Relationship of traumatic brain injury to chronic mental health problems and dementia in military veterans. Neurosci Lett. 2019;707:134294. doi:10.1016/j.neulet.2019.134294
    8. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Understanding alcohol drinking patterns. 2025. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-drinking-patterns
    9. Reid MC, Fiellin DA, O’Connor PG. Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999;159(15):1681-1689. doi:10.1001/archinte.159.15.1681
    10. MacKillop J, Agabio R, Feldstein Ewing SW, et al. Hazardous drinking and alcohol use disorders. Nat Rev Dis Primers. 2022;8(1):80. doi:10.1038/s41572-022-00406-1
    11. Hendrickson RC, Schindler AG, Pagulayan KF. Untangling PTSD and TBI: Challenges and strategies in clinical care and research. Curr Neurol Neurosci Rep. 2018;18(12):106. doi:10.1007/s11910-018-0908-5
    12. Johnson VE, Stewart W, Smith DH. Widespread tau and amyloid‐beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2012;22(2):142-149. doi:10.1111/j.1750-3639.2011.00513.x
    13. Postupna N, Rose SE, Gibbons LE, et al. The delayed neuropathological consequences of traumatic brain injury in a community-based sample. Front Neurol. 2021;12:624696. doi:10.3389/fneur.2021.624696
    14. Wilkinson CW, Pagulayan KF, Petrie EC, et al. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury. Front Neurol. 2012;3:11. doi:10.3389/fneur.2012.00011
    15. Witcher KG, Bray CE, Chunchai T, et al. Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia. J Neurosci. 2021;41(7):1597-1616. doi:10.1523/JNEUROSCI.2469-20.2020
    16. Wojtowicz M, Silverberg ND, Bui E, Zafonte R, Simon N, Iverson GL. Psychiatric comorbidity and psychosocial problems among treatment-seeking veterans with a history of mild traumatic brain injury. Focus (Am Psychiatr Publ). 2017;15(4):384-389. doi:10.1176/appi.focus.20170028
    17. Chang RC, Singleton M, Chrisman SPD, et al. Postinjury alcohol use is associated with prolonged recovery after concussion in NCAA athletes. Clin J Sport Med. 2024;34(1):30-37. doi:10.1097/JSM.0000000000001165
    18. Olson-Madden JH, Forster JE, Huggins J, Schneider A. Psychiatric diagnoses, mental health utilization, high-risk behaviors, and self-directed violence among veterans with comorbid history of traumatic brain injury and substance use disorders. J Head Trauma Rehabil. 2012;27(5):370-378. doi:10.1097/HTR.0b013e318268d496
    19. Parry-Jones BL, Vaughan FL, Miles Cox W. Traumatic brain injury and substance misuse: A systematic review of prevalence and outcomes research (1994-2004). Neuropsychol Rehabil. 2006;16(5):537-560. doi:10.1080/09602010500231875
    20. Olsen CM, Corrigan JD. Does traumatic brain injury cause risky substance use or substance use disorder? Biol Psychiatry. 2022;91(5):421-437. doi:10.1016/j.biopsych.2021.07.013
    21. Kennedy E, Cohen M, Munafò M. Childhood traumatic brain injury and the associations with risk behavior in adolescence and young adulthood: A systematic review. J Head Trauma Rehabil. 2017;32(6):425-432. doi:10.1097/HTR.0000000000000289
    22. Weil ZM, Karelina K, Corrigan JD. Does pediatric traumatic brain injury cause adult alcohol misuse: Combining preclinical and epidemiological approaches. Exp Neurol. 2019;317:284-290. doi:10.1016/j.expneurol.2019.03.012
    23. Orr TJ, Lesha E, Kramer AH, et al. Traumatic brain injury: A comprehensive review of biomechanics and molecular pathophysiology. World Neurosurg. 2024;185:74-88. doi:10.1016/j.wneu.2024.01.084
    24. Beaulieu-Bonneau S, St-Onge F, Blackburn MC, Banville A, Paradis-Giroux AA, Ouellet MC. Alcohol and drug use before and during the first year after traumatic brain injury. J Head Trauma Rehabil. 2018;33(3):E51-E60. doi:10.1097/HTR.0000000000000341
    25. Corrigan JD, Cuthbert JP, Harrison-Felix C, et al. U.S. population estimates of health and social outcomes 5 years after rehabilitation for traumatic brain injury. J Head Trauma Rehabil. 2014;29(6):E1-E9. doi:10.1097/HTR.0000000000000020
    26. Meadows SO, Engel CC, Collins RL, et al. 2015 Department of Defense Health Related Behaviors Survey (HRBS). Rand Health Q. 2018;8(2):5:.
    27. Grossbard J, Malte CA, Lapham G, et al. Prevalence of alcohol misuse and follow-up care in a national sample of OEF/OIF VA patients with and without TBI. Psychiatr Serv. 2017;68(1):48-55. doi:10.1176/appi.ps.201500290
    28. Albrecht JS, Gardner RC, Bahorik AL, Xia F, Yaffe K. Psychiatric disorders are common among older U.S. veterans prior to traumatic brain injury. J Head Trauma Rehabil. 2024;39(6):E525-E531. doi:10.1097/HTR.0000000000000959
    29. Coppel D, Barber J, Temkin NR, Mac Donald CL. Combat deployed service members by blast TBI and service separation status 5-years post-deployment: Comparison of cognitive. neurobehavioral, and psychological profiles of those who left vs. those still serving. Mil Med. 2023;189(3-4):e795-e801. doi:10.1093/milmed/usad378
    30. Jurick SM, McCabe CT, Watrous JR, et al. Associations between health-related behaviors and self-reported cognitive symptoms in U.S. military personnel injured on deployment. J Psychiatr Res. 2023;165:48-55. doi:10.1016/j.jpsychires.2023.07.001
    31. Belding JN, Englert R, Bonkowski J, Thomsen CJ. Occupational risk of low-level blast exposure and TBI-related medical diagnoses: A population-based epidemiological investigation (2005-2015). Int J Environ Res Public Health. 2021;18(24):12925. doi:10.3390/ijerph182412925
    32. Brenner LA, Forster JE, Gradus JL, et al. Associations of military-related traumatic brain injury with new-onset mental health conditions and suicide risk. JAMA Netw Open. 2023;6(7):e2326296. doi:10.1001/jamanetworkopen.2023.26296
    33. Hai T, Agimi Y, Stout K. Clusters of conditions among U.S. service members diagnosed with mild TBI from 2017 through 2019. Front Neurol. 2022;13:976892. doi:10.3389/fneur.2022.976892
    34. May AC, Hendrickson RC, Pagulayan KF, Schindler AG. An observational cohort study of alcohol use and cognitive difficulties among post-9/11 veterans with and without TBI and PTSD. Drug Alcohol Depend. 2024;263:112419. doi:10.1016/j.drugalcdep.2024.112419
    35. Schindler AG, Baskin B, Juarez B, et al. Repetitive blast mild traumatic brain injury increases ethanol sensitivity in male mice and risky drinking behavior in male combat veterans. Alcohol Clin Exp Res. 2021;45(5):1051-1064. doi:10.1111/acer.14605
    36. Steffen-Allen FT, Marton KM, Graves LV, et al. Longitudinal patterns of alcohol use following traumatic brain injury in an active duty and young veteran military sample: A VA TBI model systems study. J Head Trauma Rehabil. 2022;37(6):350-360. doi:10.1097/HTR.0000000000000757
    37. Lang B, Kerr ZY, Chandran A, et al. The longitudinal relationship between concussion history, years of American football participation, and alcohol use among former National Football League players: An NFL-LONG study. Arch Clin Neuropsychol. 2024;39(2):221-226. doi:10.1093/arclin/acad059
    38. Hind K, Konerth N, Entwistle I, et al. Mental health and wellbeing of retired elite and amateur rugby players and non-contact athletes and associations with sports-related concussion: The UK rugby health project. Sports Med. 2022;52(6):1419-1431. doi:10.1007/s40279-021-01594-8
    39. Gaetz M. Substance availability and use in ex-professional ice hockey enforcers. Sci Rep. 2022;12(1):22204. doi:10.1038/s41598-022-26806-7
    40. Wilson A, Gicas K, Wojtowicz M. Influence of mild traumatic brain injury history and mental health status on alcohol and cannabis use in university athletes. Clin J Sport Med. 2023;33(2):145-150. doi:10.1097/JSM.0000000000001110
    41. Phelps A, Alosco ML, Baucom Z, et al. Association of playing college American football with long-term health outcomes and mortality. JAMA Netw Open. 2022;5(4):e228775. doi:10.1001/jamanetworkopen.2022.8775
    42. Arango-Lasprilla JC, Watson JD, Rodríguez MJ, Ramos-Usuga D, Perrin PB. Patterns of alcohol use in Hispanic individuals with TBI over the 10 years post-injury: A model systems study. J Pers Med. 2024;14(1):105. doi: 10.3390/jpm14010105
    43. Rosenthal SR, Sonido PL, Sammartino C, Swanberg JE, Noel JK. Brain injury and substance use in young adults: The need for integrating care. R I Med J (2013). 2023;106(3):17-22.
    44. Feiss R, Corrigan JD, Ding K, Beaulieu CL, Bogner J, Yang J. Rural–urban differences in behavioral outcomes among adults with lifetime history of traumatic brain injury with loss of consciousness: 2016-2019 Ohio BRFSS. Int J Environ Res Public Health. 2022;19(3):1678. doi:10.3390/ijerph19031678
    45. Looi MC, Idris Z, Kumaran T, et al. A study of 309 patients and at one year follow-up for depression after traumatic brain injury. J Neurotrauma. 2023;40(1-2):94-101. doi: 10.1089/neu.2022.0031
    46. Matei VP, Rosca AE, Pavel AN, et al. Risk factors and consequences of traumatic brain injury in a Swiss male population cohort. BMJ Open. 2022;12(7):e055986. doi:10.1136/bmjopen-2021-055986
    47. Raj R, Kaprio J, Jousilahti P, Korja M, Siironen J. Risk of dementia after hospitalization due to traumatic brain injury: A longitudinal population-based study. Neurology. 2022;98(23):e2377-e2386. doi:10.1212/WNL.0000000000200290
    48. Wickens CM, Mann RE, Stoduto G, Toccalino D, Colantonio A, Chan V. Work-related and non-work-related mild traumatic brain injury: Associations with mental health and substance use challenges in a Canadian population-level survey. Work. 2024;79(1):331-338. doi:10.3233/WOR-230418
    49. Baskin BM, Logsdon AF, Janet Lee S, et al. Timing matters: Sex differences in inflammatory and behavioral outcomes following repetitive blast mild traumatic brain injury. Brain Behav Immun. 2023;110:222-236. doi:10.1016/j.bbi.2023.03.003
    50. Erickson EK, Grantham EK, Warden AS, Harris RA. Neuroimmune signaling in alcohol use disorder. Pharmacol Biochem Behav. 2019;177:34-60. doi:10.1016/j.pbb.2018.12.007
    51. Ghai V, Fallen S, Baxter D, et al. Alterations in plasma microRNA and protein levels in war veterans with chronic mild traumatic brain injury. J Neurotrauma. 2020;37(12):1418-1430. doi:10.1089/neu.2019.6826
    52. Hoffman J, Yu J, Kirstein C, Kindy MS. Combined effects of repetitive mild traumatic brain injury and alcohol drinking on the neuroinflammatory cytokine response and cognitive behavioral outcomes. Brain Sci. 2020;10(11):876. doi:10.3390/brainsci10110876
    53. Meabon JS, Cook DG, Yagi M, et al. Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure. J Neurol Sci. 2020;417:117049. doi:10.1016/j.jns.2020.117049
    54. Wang Z, Luo C, Zhou EW, et al. Molecular toxicology and pathophysiology of comorbid alcohol use disorder and post-traumatic stress disorder associated with traumatic brain injury. Int J Mol Sci. 2023;24(10):8805. doi:10.3390/ijms24108805
    55. Weil ZM, Corrigan JD, Karelina K. Alcohol abuse after traumatic brain injury: Experimental and clinical evidence. Neurosci Biobehav Rev. 2016;62:89-99. doi:10.1016/j.neubiorev.2016.01.005
    56. Finnegan E, Daly E, Pearce AJ, Ryan L. Nutritional interventions to support acute mTBI recovery. Front Nutr. 2022;9:977728. doi:10.3389/fnut.2022.977728
    57. Brett BL, Gardner RC, Godbout J, Dams-O’Connor K, Keene CD. Traumatic brain injury and risk of neurodegenerative disorder. Biol Psychiatry. 2022;91(5):498-507. doi:10.1016/j.biopsych.2021.05.025
    58. Khan MAS, Chang SL. Alcohol and the brain–gut axis: The involvement of microglia and enteric glia in the process of neuro-enteric inflammation. Cells. 2023;12(20):2475. doi:10.3390/cells12202475
    59. Abdul-Muneer PM, Saikia BB, Bhowmick S. Synergistic effect of mild traumatic brain injury and alcohol aggravates neuroinflammation, amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations: Impact on psychological stress. Exp Neurol. 2022;358:114222. doi:10.1016/j.expneurol.2022.114222
    60. Merkel SF, Cannella LA, Razmpour R, et al. Factors affecting increased risk for substance use disorders following traumatic brain injury: What we can learn from animal models. Neurosci Biobehav Rev. 2017;77:209-218. doi:10.1016/j.neubiorev.2017.03.015
    61. Monti K, Conkright MW, Eagle SR, Lawrence DW, Dretsch LM. The role of nutrition in mild traumatic brain injury rehabilitation for service members and veterans. NeuroRehabilitation. 2024;55(3):281-294. doi:10.3233/NRE-230241
    62. Li G, Liu H, He Y, et al. Neurological symptoms and their associations with inflammatory biomarkers in the chronic phase following traumatic brain injuries. Front Psychiatry. 2022;13:895852. doi:10.3389/fpsyt.2022.895852
    63. Malik S, Alnaji O, Malik M, Gambale T, Rathbone MP. Correlation between mild traumatic brain injury-induced inflammatory cytokines and emotional symptom traits: A systematic review. Brain Sci. 2022;12(1):102. doi:10.3390/brainsci12010102
    64. Schimmel SJ, Acosta S, Lozano D. Neuroinflammation in traumatic brain injury: A chronic response to an acute injury. Brain Circ. 2017;3(3):135-142. doi:10.4103/bc.bc_18_17
    65. Dong X, Su Y, Luo Z, et al. Fecal microbiota transplantation alleviates cognitive impairment by improving gut microbiome composition and barrier function in male rats of traumatic brain injury following gas explosion. Front Microbiol. 2024;15:1485936. doi:10.3389/fmicb.2024.1485936
    66. Frankot MA, O’Hearn CM, Blancke AM, et al. Acute gut microbiome changes after traumatic brain injury are associated with chronic deficits in decision-making and impulsivity in male rats. Behav Neurosci. 2023;137(1):15-28. doi:10.1037/bne0000532
    67. Leclercq S. Involvement of the gut microbiome-brain axis in alcohol use disorder. Alcohol Alcohol. 2024;59(5):agae050. doi:10.1093/alcalc/agae050
    68. Shukla PK, Meena AS, Dalal K, et al. Chronic stress and corticosterone exacerbate alcohol-induced tissue injury in the gut-liver-brain axis. Sci Rep. 2021;11(1):826. doi:10.1038/s41598-020-80637-y
    69. Wang C, Yan J, Du K, et al. Intestinal microbiome dysbiosis in alcohol-dependent patients and its effect on rat behaviors. mBio. 2023;14(6):e0239223. doi:10.1128/mbio.02392-23
    70. Bode C, Bode JC. Alcohol’s role in gastrointestinal tract disorders. Alcohol Health Res World. 1997;21(1):76-83.
    71. You W, Zhu Y, Wei A, et al. Traumatic brain injury induces gastrointestinal dysfunction and dysbiosis of gut microbiota accompanied by alterations of bile acid profile. J Neurotrauma. 2022;39(1-2):227-237. doi:10.1089/neu.2020.7526
    72. Aghakhani N. Relationship between mild traumatic brain injury and the gut microbiome: A scoping review. J Neurosci Res. 2022;100(3):827-834. doi:10.1002/jnr.25004
    73. El Baassiri MG, Raouf Z, Badin S, Escobosa A, Sodhi CP, Nasr IW. Dysregulated brain-gut axis in the setting of traumatic brain injury: Review of mechanisms and anti-inflammatory pharmacotherapies. J Neuroinflammation. 2024;21(1):124. doi:10.1186/s12974-024-03118-3
    74. Abdul-Muneer PM, Chandra N, Haorah J. Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol. 2015;51(3):966-979. doi:10.1007/s12035-014-8752-3
    75. Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, Persidsky Y. Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med. 2008;45(11):1542-1550. doi:10.1016/j.freeradbiomed.2008.08.030
    76. Logsdon AF, Meabon JS, Cline MM, et al. Blast exposure elicits blood-brain barrier disruption and repair mediated by tight junction integrity and nitric oxide dependent processes. Sci Rep. 2018;8(1):11344. doi:10.1038/s41598-018-29341-6
    77. Wang C, Shao C, Zhang L, et al. Oxidative stress signaling in blast TBI-induced tau phosphorylation. Antioxidants. 2021;10(6):955. doi:10.3390/antiox10060955
    78. Logsdon AF, Schindler AG, Meabon JS, et al. Nitric oxide synthase mediates cerebellar dysfunction in mice exposed to repetitive blast-induced mild traumatic brain injury. Sci Rep. 2020;10(1):9420. doi:10.1038/s41598-020-66113-7
    79. Zhang Z, Xiao T, Hall MR, et al. Temporal differential effects of post-injury alcohol consumption in a mouse model of blast-induced traumatic brain injury. Neuroscience. 2024;562:239-251. doi:10.1016/j.neuroscience.2024.10.003
    80. Rehm J, Hasan OSM, Black SE, Shield KD, Schwarzinger M. Alcohol use and dementia: A systematic scoping review. Alzheimers Res Ther. 2019;11(1):1. doi:10.1186/s13195-018-0453-0
    81. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278. doi:10.1016/j.cell.2022.11.001
    82. Schwartzenburg JB, Cruise SC, Reed RE, et al. Neuropathological outcomes of traumatic brain injury and alcohol use in males and females: Studies using pre-clinical rodent and clinical human specimens. J Neurotrauma. 2023;40(21-22):2410-2426. doi:10.1089/neu.2023.0074
    83. Walsh M, Uretsky M, Tripodis Y, et al. Clinical and neuropathological correlates of substance use in American football players. J Alzheimers Dis. 2024;101(3):971-986. doi:10.3233/JAD-240300
    84. Hoxha V, Shrestha G, Baloch N, Collevechio S, Laszczyk R, Roman G. TBI and tau loss of function both affect naïve ethanol sensitivity in drosophila. Int J Mol Sci. 2024;25(6):3301. doi:10.3390/ijms25063301
    85. Simmons KE, Healey KL, Li Q, Moore SD, Klein RC. Effects of sex and genotype in human APOE-targeted replacement mice on alcohol self-administration measured with the automated IntelliCage system before and after repeated mild traumatic brain injury. Alcohol Clin Exp Res. 2021;45(11):2231-2245. doi:10.1111/acer.14717
    86. Dennis EL, Taylor BA, Newsome MR, et al. Advanced brain age in deployment-related traumatic brain injury: A LIMBIC-CENC neuroimaging study. Brain Inj. 2022;36(5):662-672. doi:10.1080/02699052.2022.2033844
    87. Matsuda H. Voxel-based morphometry of brain MRI in normal aging and Alzheimer’s disease. Aging Dis. 2013;4(1):29-37.
    88. Newcombe VFJ, Ashton NJ, Posti JP, et al. Post-acute blood biomarkers and disease progression in traumatic brain injury. Brain. 2022;145(6):2064-2076. doi:10.1093/brain/awac126
    89. Rojczyk P, Heller C, Seitz-Holland J, et al. Intimate partner violence perpetration among veterans: Associations with neuropsychiatric symptoms and limbic microstructure. Front Neurol. 2024;15:1360424. doi:10.3389/fneur.2024.1360424
    90. Baranger DAA, Demers CH, Elsayed NM, et al. Convergent evidence for predispositional effects of brain gray matter volume on alcohol consumption. Biol Psychiatry. 2020;87(7):645-655. doi:10.1016/j.biopsych.2019.08.029
    91. Blaine SK, Sinha R. Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders. Neuropharmacology. 2017;122:136-147. doi:10.1016/j.neuropharm.2017.01.037
    92. Feinberg C, Mayes KD, Portman E, Carr C, Mannix R. Non-invasive fluid biomarkers in the diagnosis of mild traumatic brain injury (mTBI): A systematic review. J Neurol Neurosurg Psychiatry. 2024;95(2):184-192. doi:10.1136/jnnp-2023-331220
    93. Schindler AG, Terry GE, Wolden-Hanson T, et al. Repetitive Blast Promotes chronic aversion to neutral cues encountered in the peri-blast environment. J Neurotrauma. 2021;38(7):940-948. doi:10.1089/neu.2020.7061
    94. Stephens MAC, Wand G. Stress and the HPA axis: Role of glucocorticoids in alcohol dependence. Alcohol Res. 2012;34(4):468-483.
    95. Zuckerman A, Ram O, Ifergane G, et al. Role of endogenous and exogenous corticosterone on behavioral and cognitive responses to low-pressure blast wave exposure. J Neurotrauma. 2019;36(2):380-394. doi:10.1089/neu.2018.5672
    96. Frendl I, Erdei A, Zsiros N, et al. Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury. Neuro Endocrinol Lett. 2022;43(4):239-245.
    97. Ramos‐Cejudo J, Genfi A, Abu‐Amara D, et al. CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans. Psychiatr Res Clin Pract. 2021;3(4):153-162. doi:10.1176/appi.prcp.20210017
    98. Van’t Veer A, Carlezon WA. Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacol. 2013;229(3):435-452. doi:10.1007/s00213-013-3195-5
    99. Best KM, Mojena MM, Barr GA, Schmidt HD, Cohen AS. Endogenous opioid dynorphin is a potential link between traumatic brain injury, chronic pain, and substance use disorder. J Neurotrauma. 2022;39(1-2):1-19. doi:10.1089/neu.2021.0063
    100. Leconte C, Mongeau R, Noble F. Traumatic stress-induced vulnerability to addiction: Critical role of the dynorphin/kappa Opioid receptor system. Front Pharmacol. 2022;13:856672. doi:10.3389/fphar.2022.856672
    101. Lee SJ, Logsdon AF, Yagi M, et al. The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma. J Neuroinflammation. 2022;19(1):288. doi:10.1186/s12974-022-02643-3
    102. Chavkin C, Ehrich JM. How does stress-induced activation of the kappa opioid system increase addiction risk? Biol Psychiatry. 2014;76(10):760-762. doi:10.1016/j.biopsych.2014.08.015
    103. Chavkin C, Koob GF. Dynorphin, Dysphoria, and dependence: The stress of addiction. Neuropsychopharmacology. 2016;41(1):373-374. doi:10.1038/npp.2015.258
    104. Ehrich JM, Phillips PEM, Chavkin C. Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens. Neuropsychopharmacology. 2014;39(13):3036-3048. doi:10.1038/npp.2014.157
    105. Ehrich JM, Messinger DI, Knakal CR, et al. Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons. J Neurosci. 2015;35(37):12917-12931. doi:10.1523/JNEUROSCI.2444-15.2015
    106. Tejeda HA, Bonci A. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders. Brain Res. 2019;1713:91-101. doi:10.1016/j.brainres.2018.09.023
    107. de Assis GG, Gasanov EV. BDNF and cortisol integrative system—Plasticity vs. degeneration: Implications of the Val66Met polymorphism. Front Neuroendocrinol. 2019;55:100784. doi:10.1016/j.yfrne.2019.100784
    108. Miao Z, Wang Y, Sun Z. The relationships between stress, mental disorders, and epigenetic regulation of BDNF. Int J Mol Sci. 2020;21(4):1375. doi:10.3390/ijms21041375
    109. Gustafsson D, Klang A, Thams S, Rostami E. The role of BDNF in experimental and clinical traumatic brain injury. Int J Mol Sci. 2021;22(7):3582. doi:10.3390/ijms22073582
    110. Kim HJ, Tsao JW, Stanfill AG. The current state of biomarkers of mild traumatic brain injury. JCI Insight. 2018;3(1):e97105. doi:10.1172/jci.insight.97105
    111. Lesniak A, Poznański P, Religa P, Nawrocka A, Bujalska-Zadrozny M, Sacharczuk M. Loss of brain-derived neurotrophic factor (BDNF) resulting from congenital- or mild traumatic brain injury-induced blood-brain barrier disruption correlates with depressive-like behaviour. Neuroscience. 2021;458:1-10. doi:10.1016/j.neuroscience.2021.01.013
    112. Peregud DI, Baronets VY, Terebilina NN, Gulyaeva NV. Role of BDNF in neuroplasticity associated with alcohol dependence. Biochemistry. 2023;88(3):404-416. doi:10.1134/S0006297923030094
    113. Logrip ML, Barak S, Warnault V, Ron D. Corticostriatal BDNF and alcohol addiction. Brain Res. 2015;1628(A):60-67. doi:10.1016/j.brainres.2015.03.025
    114. Kim JM, Kang HJ, Kim JW, et al. Delayed effects of alcohol consumption on the association between serum BDNF levels and post-traumatic stress disorder development over two-years. Prog Neuropsychopharmacol Biol Psychiatry. 2024;135:111106. doi:10.1016/j.pnpbp.2024.111106
    115. Basavarajappa BS. Endocannabinoid system and alcohol abuse disorders. Adv Exp Med Biol. 2019;1162:89-127. doi:10.1007/978-3-030-21737-2_6
    116. Kunos G. Interactions between alcohol and the endocannabinoid system. Alcohol Clin Exp Res. 2020;44(4):790-805. doi:10.1111/acer.14306
    117. Schurman LD, Lichtman AH. Endocannabinoids: A promising impact for traumatic brain injury. Front Pharmacol. 2017;8:69. doi:10.3389/fphar.2017.00069
    118. Pacher P, Bátkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462. doi:10.1124/pr.58.3.2
    119. Fucich EA, Mayeux JP, McGinn MA, Gilpin NW, Edwards S, Molina PE. A novel role for the endocannabinoid system in ameliorating motivation for alcohol drinking and negative behavioral affect after traumatic brain injury in rats. J Neurotrauma. 2019;36(11):1847-1855. doi:10.1089/neu.2018.5854
    120. Katz PS, Sulzer JK, Impastato RA, Teng SX, Rogers EK, Molina PE. Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. J Neurotrauma. 2015;32(5):297-306. doi:10.1089/neu.2014.3508
    121. Mayeux J, Katz P, Edwards S, Middleton JW, Molina PE. Inhibition of endocannabinoid degradation improves outcomes from mild traumatic brain injury: A mechanistic role for synaptic hyperexcitability. J Neurotrauma. 2017;34(2):436-443. doi:10.1089/neu.2016.4452
    122. Jacotte-Simancas A, Molina PE, Gilpin NW. Repeated mild traumatic brain injury and JZL184 produce sex-specific increases in anxiety-like behavior and alcohol consumption in Wistar rats. J Neurotrauma. 2023;40(21-22):2427-2441. doi:10.1089/neu.2023.0088
    123. Siciliano CA, Karkhanis AN, Holleran KM, Melchior JR, Jones SR. Cross-species alterations in synaptic dopamine regulation after chronic alcohol exposure. Handb Exp Pharmacol. 2018;248:213-238. doi:10.1007/164_2018_106
    124. Gallant C, Good D. Alcohol misuse and traumatic brain injury: A review of the potential roles of dopaminergic dysfunction and physiological underarousal post-injury. Appl Neuropsychol Adult. 2021;28(5):501-511. doi:10.1080/23279095.2019.1670181
    125. McAllister TW, Flashman LA, McDonald BC, et al. Dopaminergic challenge with bromocriptine one month after mild traumatic brain injury: Altered working memory and BOLD response. J Neuropsychiatry Clin Neurosci. 2011;23(3):277-286. doi:10.1176/jnp.23.3.jnp277
    126. Rabinowitz AR, Watanabe TK. Pharmacotherapy for treatment of cognitive and neuropsychiatric symptoms after mTBI. J Head Trauma Rehabil. 2020;35(1):76-83. doi:10.1097/HTR.0000000000000537
    127. Schindler AG, Meabon JS, Pagulayan KF, et al. Blast–related disinhibition and risk seeking in mice and combat Veterans: Potential role for dysfunctional phasic dopamine release. Neurobiol Dis. 2017;106:23-34. doi:10.1016/j.nbd.2017.06.004
    128. Kraus MF, Susmaras T, Caughlin BP, Walker CJ, Sweeney JA, Little DM. White matter integrity and cognition in chronic traumatic brain injury: A diffusion tensor imaging study. Brain. 2007;130(10):2508-2519. doi:10.1093/brain/awm216
    129. Bales JW, Kline AE, Wagner AK, Dixon CE. Targeting dopamine in acute traumatic brain injury. Open Drug Discov J. 2010;2:119-128. doi:10.2174/1877381801002010119
    130. Iannucci J, O’Neill K, Wang X, Mukherjee S, Wang J, Shapiro LA. Sex-specific and traumatic brain injury effects on dopamine receptor expression in the hippocampus. Int J Mol Sci. 2023;24(22):16084. doi:10.3390/ijms242216084
    131. Söderpalm B, Ericson M. Alcohol and the dopamine system. Int Rev Neurobiol. 2024;175:21-73. doi:10.1016/bs.irn.2024.02.003
    132. Wise RA, Jordan CJ. Dopamine, behavior, and addiction. J Biomed Sci. 2021;28(1):83. doi:10.1186/s12929-021-00779-7
    133. Melugin PR, Nolan SO, Siciliano CA. Bidirectional causality between addiction and cognitive deficits. Int Rev Neurobiol. 2021;157:371-407. doi:10.1016/bs.irn.2020.11.001
    134. Jorge RE, Arciniegas DB. Mood disorders after TBI. Psychiatr Clin North Am. 2014;37(1):13-29. doi:10.1016/j.psc.2013.11.005
    135. Otero MC, Rau HK, Shofer JB, Peskind ER, Pagulayan KF. Self-perceived irritability among OEF/OIF/OND veterans with a history of deployment-related mTBI: Associations with prospective memory and quality of life. Clin Neuropsychol. 2022;36(6):1384-1404. doi:10.1080/13854046.2020.1856413
    136. Ozga JE, Povroznik JM, Engler-Chiurazzi EB, Vonder Haar CV. Executive (dys)function after traumatic brain injury: Special considerations for behavioral pharmacology. Behav Pharmacol. 2018;29(7):617-637. doi:10.1097/FBP.0000000000000430
    137. Challakere Ramaswamy VMC, Butler T, Ton B, et al. Self-reported traumatic brain injury in a sample of impulsive violent offenders: Neuropsychiatric correlates and possible “dose effects.” Front Psychol. 2023;14:1243655. doi:10.3389/fpsyg.2023.1243655
    138. Clark JMR, Mahmood Z, Jak AJ, et al. Neuropsychological performance and functional capacity following mild traumatic brain injury in veterans. J Head Trauma Rehabil. 2022;37(6):E488-E495. doi:10.1097/HTR.0000000000000748
    139. Rau HK, Sheppard DP, Karr JE, et al. Neurocognitive intraindividual variability in veterans with mild traumatic brain injury history and posttraumatic stress disorder. Arch Clin Neuropsychol. 2025;40(3):425-436. doi:10.1093/arclin/acae098
    140. Sheppard DP, Rau HK, Trittschuh EH, et al. Poorer prospective memory performance is associated with reduced time monitoring among OEF/OIF/OND Veterans with a history of blast-related mild traumatic brain injury. Clin Neuropsychol. 2023;37(3):577-594. doi:10.1080/13854046.2022.2068455
    141. Bales JW, Wagner AK, Kline AE, Dixon CE. Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev. 2009;33(7):981-1003. doi:10.1016/j.neubiorev.2009.03.011
    142. Berridge KC. The debate over dopamine’s role in reward: The case for incentive salience. Psychopharmacol. 2007;191(3):391-431. doi:10.1007/s00213-006-0578-x
    143. Berridge KC, Robinson TE. Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol. 2016;71(8):670-679. doi:10.1037/amp0000059
    144. Bowirrat A, Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet. 2005;132B(1):29-37. doi:10.1002/ajmg.b.30080
    145. Koob GF, Volkow ND. Neurobiology of addiction: A neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760-773. doi:10.1016/S2215-0366(16)00104-8
    146. Vandaele Y, Ahmed SH. Habit, choice, and addiction. Neuropsychopharmacology. 2021;46(4):689-698. doi:10.1038/s41386-020-00899-y
    147. Vandaele Y, Daeppen JB. From concepts to treatment: A dialog between a preclinical researcher and a clinician in addiction medicine. Transl Psychiatry. 2022;12(1):401. doi:10.1038/s41398-022-02177-5
    148. Wood RL, McHugh L. Decision making after traumatic brain injury: A temporal discounting paradigm. J Int Neuropsychol Soc. 2013;19(2):181-188. doi:10.1017/S135561771200118X
    149. Bjork JM, Reisweber J, Perrin PB, Plonski PE, Dismuke-Greer CE. Neurocognitive function and medical care utilization in Veterans treated for substance use disorder. Subst Abuse Treat Prev Policy. 2024;19(1):39. doi:10.1186/s13011-024-00621-x
    150. Kintu TM, Katengeke V, Kamoga R, et al. Cognitive impairment following traumatic brain injury in Uganda: Prevalence and associated factors. PLOS Glob Public Health. 2023;3(2):e0001459. doi:10.1371/journal.pgph.0001459
    151. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: A systematic review. Age Ageing. 2008;37(5):505-512. doi:10.1093/ageing/afn095
    152. Reas ET, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E, McEvoy LK. Moderate, regular alcohol consumption is associated with higher cognitive function in older community-dwelling adults. J Prev Alzheimers Dis. 2016;3(2):105-113. doi:10.14283/jpad.2016.89
    153. Zhang R, Shen L, Miles T, et al. Association of low to moderate alcohol drinking with cognitive functions from middle to older age among U.S. adults. JAMA Netw Open. 2020;3(6):e207922. doi:10.1001/jamanetworkopen.2020.7922
    154. Krivanek TJ, Gale SA, McFeeley BM, Nicastri CM, Daffner KR. Promoting successful cognitive aging: A ten-year update. J Alzheimers Dis. 2021;81(3):871-920. doi:10.3233/JAD-201462
    155. Hassing LB. Light alcohol consumption does not protect cognitive function: A longitudinal prospective study. Front Aging Neurosci. 2018;10:81. doi:10.3389/fnagi.2018.00081
    156. Baskin B, Lee SJ, Skillen E, et al. Repetitive Blast Exposure increases appetitive motivation and behavioral inflexibility in male mice. Front Behav Neurosci. 2021;15:792648. doi:10.3389/fnbeh.2021.792648
    157. Sleep CE, Weiss B, Lynam DR, Miller JD. An examination of the Triarchic Model of psychopathy’s nomological network: A meta-analytic review. Clin Psychol Rev. 2019;71:1-26. doi:10.1016/j.cpr.2019.04.005
    158. Flagel SB, Robinson TE, Clark JJ, et al. An animal model of genetic vulnerability to behavioral disinhibition and responsiveness to reward-related cues: Implications for addiction. Neuropsychopharmacology. 2010;35(2):388-400. doi:10.1038/npp.2009.142
    159. Jupp B, Dalley JW. Convergent pharmacological mechanisms in impulsivity and addiction: Insights from rodent models. Br J Pharmacol. 2014;171(20):4729-4766. doi:10.1111/bph.12787
    160. Theadom A, Jones K, Starkey N, et al. Symptoms and engagement in anti-social behavior 10 years after mild traumatic brain injury within a community civilian sample: A prospective cohort study with age-sex matched control group. Arch Phys Med Rehabil. 2024;105(2):295-302. doi:10.1016/j.apmr.2023.07.016
    161. Puddephatt JA, Irizar P, Jones A, Gage SH, Goodwin L. Associations of common mental disorder with alcohol use in the adult general population: A systematic review and meta-analysis. Addiction. 2022;117(6):1543-1572. doi:10.1111/add.15735
    162. Metzger IW, Blevins C, Calhoun CD, et al. An examination of the impact of maladaptive coping on the association between stressor type and alcohol use in college. J Am Coll Health. 2017;65(8):534-541. doi:10.1080/07448481.2017.1351445
    163. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33-51. doi:10.1037/0033-295X.111.1.33
    164. Epstein EL, Martindale SL, et al. Posttraumatic stress disorder and traumatic brain injury: Sex differences in veterans. Psychiatry Res. 2019;274:105-111. doi:10.1016/j.psychres.2019.01.097
    165. Keyes KM. Alcohol use in the older adult U.S. population: Trends, causes, and consequences. Alcohol. 2023;107:28-31. doi:10.1016/j.alcohol.2022.05.005
    166. Waltzman D, Haarbauer-Krupa J, Womack LS. Traumatic brain injury in older adults—A public health perspective. JAMA Neurol. 2022;79(5):437-438. doi:10.1001/jamaneurol.2022.0114

    Last Date Updated: